Drugs / recombinant vaccinia-MUC1 vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00071942 | Oct 2003 → Nov 2007 | male breast carcinoma | National Cancer Institute (NCI) | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant vaccinia-MUC1 vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00071942 ↗ |
| Modality | Vaccine | “Vaccines may make the body build an immune response to kill tumor cells.” NCT00071942 ↗ |